These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 11181984

  • 1. Randomized placebo-controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus.
    Kvetny J, Gregersen G, Pedersen RS.
    QJM; 2001 Feb; 94(2):89-94. PubMed ID: 11181984
    [Abstract] [Full Text] [Related]

  • 2. Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria.
    Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, Raffaele J, Tsalamandris C.
    Am J Kidney Dis; 2001 May; 37(5):890-9. PubMed ID: 11325669
    [Abstract] [Full Text] [Related]

  • 3. Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM.
    Penno G, Chaturvedi N, Talmud PJ, Cotroneo P, Manto A, Nannipieri M, Luong LA, Fuller JH.
    Diabetes; 1998 Sep; 47(9):1507-11. PubMed ID: 9726242
    [Abstract] [Full Text] [Related]

  • 4. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, O'Brien RC, Raffaele J, Tsalamandris C, Melbourne Diabetic Nephropathy Study Group.
    Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
    [Abstract] [Full Text] [Related]

  • 5. ACE DD genotype is more susceptible than ACE II and ID genotypes to the antiproteinuric effect of ACE inhibitors in patients with proteinuric non-insulin-dependent diabetes mellitus.
    Ha SK, Yong Lee S, Su Park H, Ho Shin J, Jung Kim S, Hun Kim D, Rae Kim K, Yung Lee H, Suk Han D.
    Nephrol Dial Transplant; 2000 Oct; 15(10):1617-23. PubMed ID: 11007831
    [Abstract] [Full Text] [Related]

  • 6. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.
    Ravid M, Brosh D, Levi Z, Bar-Dayan Y, Ravid D, Rachmani R.
    Ann Intern Med; 1998 Jun 15; 128(12 Pt 1):982-8. PubMed ID: 9625684
    [Abstract] [Full Text] [Related]

  • 7. Modulation of the renal response to ACE inhibition by ACE insertion/deletion polymorphism during hyperglycemia in normotensive, normoalbuminuric type 1 diabetic patients.
    Weekers L, Bouhanick B, Hadjadj S, Gallois Y, Roussel R, Pean F, Ankotche A, Chatellier G, Alhenc-Gelas F, Lefebvre PJ, Marre M.
    Diabetes; 2005 Oct 15; 54(10):2961-7. PubMed ID: 16186399
    [Abstract] [Full Text] [Related]

  • 8. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME.
    J Hypertens Suppl; 1996 Dec 15; 14(6):S11-4. PubMed ID: 9023709
    [Abstract] [Full Text] [Related]

  • 9. Effects of perindopril on renal histomorphometry in diabetic subjects with microalbuminuria: a 3-year placebo-controlled biopsy study.
    Nankervis A, Nicholls K, Kilmartin G, Allen P, Ratnaike S, Martin FI.
    Metabolism; 1998 Dec 15; 47(12 Suppl 1):12-5. PubMed ID: 9867064
    [Abstract] [Full Text] [Related]

  • 10. [Long-term decrease of microalbuminuria after one year of treatment with perindopril in hypertensive diabetic patients].
    Brichard SM, Santoni JP, Thomas JR, Van de Voorde K, Ketelslegers JM, Lambert AE.
    Ann Cardiol Angeiol (Paris); 1990 Oct 15; 39(8):495-9. PubMed ID: 2281920
    [Abstract] [Full Text] [Related]

  • 11. Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?
    Andersen S, Tarnow L, Cambien F, Rossing P, Juhl TR, Deinum J, Parving HH.
    Diabetes Care; 2003 May 15; 26(5):1501-6. PubMed ID: 12716812
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed Up for 9 years.
    Huang XH, Rantalaiho V, Wirta O, Pasternack A, Hiltunen TP, Koivula T, Malminiemi K, Nikkari T, Lehtimäki T.
    Nephron; 1998 Sep 15; 80(1):17-24. PubMed ID: 9730698
    [Abstract] [Full Text] [Related]

  • 13. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
    Chan JC, Ko GT, Leung DH, Cheung RC, Cheung MY, So WY, Swaminathan R, Nicholls MG, Critchley JA, Cockram CS.
    Kidney Int; 2000 Feb 15; 57(2):590-600. PubMed ID: 10652036
    [Abstract] [Full Text] [Related]

  • 14. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
    Parving HH, Jacobsen P, Tarnow L, Rossing P, Lecerf L, Poirier O, Cambien F.
    BMJ; 1996 Sep 07; 313(7057):591-4. PubMed ID: 8806248
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy.
    Jacobsen P, Rossing K, Rossing P, Tarnow L, Mallet C, Poirier O, Cambien F, Parving HH.
    Kidney Int; 1998 Apr 07; 53(4):1002-6. PubMed ID: 9551410
    [Abstract] [Full Text] [Related]

  • 16. Long term reduction of microalbuminuria after 1 year of angiotensin converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients.
    Brichard SM, Santoni JP, Thomas JR, van de Voorde K, Ketelslegers JM, Lambert AE.
    Diabete Metab; 1990 Apr 07; 16(1):30-6. PubMed ID: 2185055
    [Abstract] [Full Text] [Related]

  • 17. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
    Sjølie AK, Chaturvedi N, Fuller J.
    Ugeskr Laeger; 1999 Feb 15; 161(7):949-52. PubMed ID: 10051804
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin-converting enzyme genotype, albuminuria and plasma fibrinogen in type 2 diabetes mellitus.
    Tkác I, Salagovic J, Kozárová M, Javorský M, Tkácová R, Kalina I.
    Wien Klin Wochenschr; 2003 Dec 15; 115(23):835-9. PubMed ID: 14740347
    [Abstract] [Full Text] [Related]

  • 19. [Protective effect of angiotensin coverting enzyme inhibitor on renal function in normotensive non-insulin dependent diabetes mellitus patients with early diabetic nephropathy and microalbuminuria].
    Xia H, He R, Chen J.
    Zhonghua Nei Ke Za Zhi; 1996 Aug 15; 35(8):533-6. PubMed ID: 9594145
    [Abstract] [Full Text] [Related]

  • 20. A double-blind trial of perindopril and nitrendipine in incipient diabetic nephropathy.
    Kopf D, Schmitz H, Beyer J, Frank M, Bockisch A, Lehnert H.
    Diabetes Nutr Metab; 2001 Oct 15; 14(5):245-52. PubMed ID: 11806464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.